Related Experiment Video
Updated: Sep 7, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Brevibacterium casei Induced Peritonitis in a Patient Undergoing Continuous Cycler Peritoneal Dialysis: Case Report
Sasmit Roy1, Amarinder S Garcha2, Sumit S Patel3
1Department of Medicine, Centra Lynchburg General Hospital, 1901 Tate Springs Road, Lynchburg, VA 24501, USA.
Abstract:
Brevibacterium casei is an extremely rare organism that can lead to peritonitis in End-stage renal disease patients of peritoneal dialysis. Out of only five overall Brevibacterium species peritonitis reported worldwide, only two of them had B. casei subspecies peritonitis detected, with both needing peritoneal dialysis catheter removal and change in dialysis modality to hemodialysis. Our patient, an elderly 63-year-old Hispanic male, was on peritoneal dialysis at home and presented with features suggestive of peritonitis. He was diagnosed subsequently with B. casei and started on broad spectrum intraperitoneal antibiotics. However, he did not need dialysis modality change and recovered fully after 3 weeks of appropriate intraperitoneal antibiotics therapy. Longer antibiotics therapy and frequent clinical follow-up plus better clinician awareness are needed to prevent this rare infection.
Insights
Brevibacterium casei peritonitis is rare in peritoneal dialysis patients. This case highlights successful treatment with antibiotics alone, avoiding dialysis changes.
Area of Science:
- Microbiology
- Nephrology
- Infectious Diseases
Background:
- Peritonitis is a serious complication for patients undergoing peritoneal dialysis (PD).
- Brevibacterium species, particularly Brevibacterium casei, are extremely rare causes of PD-associated peritonitis.
- Previous reported cases necessitated surgical intervention and changes in dialysis modality.
Observation:
- A 63-year-old male on home PD presented with clinical signs of peritonitis.
- Diagnosis confirmed Brevibacterium casei infection.
- The patient received broad-spectrum intraperitoneal antibiotics.
Findings:
- Unlike previous reports, this patient did not require PD catheter removal.
- Full recovery was achieved within three weeks of targeted intraperitoneal antibiotic therapy.
- This case represents a successful non-surgical management of B. casei peritonitis.
Implications:
- Brevibacterium casei peritonitis, though rare, is treatable with prolonged intraperitoneal antibiotics.
- Clinician awareness and vigilant monitoring are crucial for managing such infections.
- Conservative management may be possible, potentially avoiding dialysis modality shifts.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Continuous Renal Replacement Therapy
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Acute Kidney Injury V: Interprofessional Care

